Natural Products as Xanthine Oxidase Inhibitors: A Promising Approach for Hyperuricemia and Gout Management

Introduction: Xanthine oxidase (XO) is an essential enzyme in purine metabolism, catalyzing the oxidation of hypoxanthine to xanthine and then to uric acid. The hyperactivity of xanthine oxidase is associated with hyperuricemia and gout, necessitating effective inhibitors. Synthetic inhibitors like allopurinol and febuxostat are commonly utilized; yet, their considerable side effects have sparked curiosity in natural alternatives. Methods: This paper reviews current advancements in the identification and characterization of natural xanthine oxidase inhibitors derived from medicinal plants, fungi, and marine organisms. Focus is directed towards phytochemical content, mechanisms of action, and inhibitory effectiveness, as evidenced by in vitro and in vivo research. Results: Numerous bioactive compounds, including flavonoids, phenolics, alkaloids, and terpenoids, have shown significant xanthine oxidase inhibitory activity. These natural inhibitors exhibit a variety of mechanisms, including competitive, non-competitive, and mixed-type inhibition, and are typically associated with additional antioxidant activities. Phytochemicals from a variety of sources show promising efficacy and safety features. Discussion: Natural XO inhibitors provide a multi-targeted approach with fewer side effects than manufactured medicines. However, issues persist in terms of bioavailability, pharmacokinetics, and standardization. Advances in molecular docking and drug delivery technology help them develop as safer alternatives. Conclusion: Natural products are promising candidates for XO inhibition, providing potential therapeutic benefits for hyperuricemia and gout. Further clinical studies and formulation standardization are essential for translating these findings into practical treatments.